Results 51 to 60 of about 1,252,486 (261)
Thorax, 2021 Objectives Chronic pulmonary aspergillosis (CPA) can complicate recovery from pulmonary TB. CPA may also be misdiagnosed as bacteriologically negative TB.
F. Setianingrum +14 more
semanticscholar +1 more source
Diagnostic and Interventional Imaging, 2015 Aspergillosis is a mycotic disease usually caused by Aspergillus fumigatus, a saprophytic and ubiquitous airborne fungus. Aspergillus-related lung diseases are traditionally classified into four different forms, whose occurrence depends on the immunologic status of the host and the existence of an underlying lung disease.
Chabi, M.L. +5 more
openaire +2 more sources
Germination of Aspergillus fumigatus inside avian respiratory macrophages is associated with cytotoxicity [PDF]
, 2012 Although aspergillosis is one of the most common diseases in captive birds, the pathogenesis of avian aspergillosis is poorly known. We studied the role of avian respiratory macrophages as a first line of defense against avian aspergillosis.
D'Herde, Katharina +7 more
core +2 more sources
Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis
European Respiratory Journal, 2021 Chronic pulmonary aspergillosis (CPA) is an emerging disease in patients with common chronic pulmonary diseases (CPDs). While its prevalence is linked to tuberculosis (TB) in endemic countries, epidemiological and prognostic data are lacking in low TB ...
T. Maitre +9 more
semanticscholar +1 more source
Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report. [PDF]
, 2021 It is not yet known, if critically ill COVID-19 patients are prone to fungal infections. We report a 69-year-old patient without typical risk factors for invasive pulmonary aspergillosis (IPA), who developed IPA two weeks after onset of symptoms.
Eller, Philipp +5 more
core
COVID‐19–associated pulmonary aspergillosis: a prospective single‐center dual case series
Mycoses (Berlin), 2021 COVID‐19–associated pulmonary aspergillosis (CAPA) has emerged as an invasive fungal disease, often affecting previously immunocompetent, mechanically ventilated, intensive care unit (ICU) patients.
Eelco F. J. Meijer +3 more
semanticscholar +1 more source
Single dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model [PDF]
, 2013 Conventional MIC testing of amphotericin B results in narrow MIC ranges challenging the detection of resistant strains. In order to discern amphotericin B pharmacodynamics, the in vitro activity of amphotericin B was studied against Aspergillus isolates ...
Al-Saigh, Rafal +5 more
core +1 more source
Mycoses (Berlin), 2021 An increasing number of cases of invasive pulmonary aspergillosis (IPA) complicating influenza have been described. We performed a meta‐analysis to estimate the incidence, risk factors and outcomes of IPA in patients with influenza.
Changcheng Shi +8 more
semanticscholar +1 more source
Pathogenicity and virulence of Aspergillus fumigatus
Virulence, 2023 Pulmonary infections caused by the mould pathogen Aspergillus fumigatus are a major cause of morbidity and mortality globally. Compromised lung defences arising from immunosuppression, chronic respiratory conditions or more recently, concomitant viral or
Kayleigh Earle +7 more
doaj +1 more source
Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statement
European Respiratory Journal, 2022 Chronic pulmonary aspergillosis (CPA) is an uncommon but dreaded complication of many respiratory diseases occurring in non- or mildly immunocompromised patients [1].
E. Van Braeckel +28 more
semanticscholar +1 more source